Osteoradionecrosis versus Cancer Recurrence: An Unresolved Clinical Dilemma

Area of Science:

• Oncology
• Radiology
• Nuclear Medicine

Background:

• Osteoradionecrosis (ORN) is a serious complication of head and neck cancer chemoradiotherapy.
• Differentiating ORN from recurrent or progressive cancer is clinically challenging due to similar presentations.

Purpose of the Study:

• To compare the clinical and radiologic features of osteonecrosis with recurrent or progressive head and neck cancer.
• To identify potential diagnostic markers for distinguishing between ORN and malignancy.

Main Methods:

• A single-center case series of 19 patients with head and neck squamous cell carcinoma.
• Review of clinician notes and imaging reports for final diagnosis (cancer, osteonecrosis, or indeterminate).
• Analysis of clinical presentation, radiologic features, and PET/CT SUVmax values.

Main Results:

• No significant differences in clinical or radiologic features between ORN and cancer groups.
• Median time to symptom development was longer for ORN (5 months) vs. cancer (3 months), not statistically significant.
• Significantly higher SUVmax on PET/CT in the cancer group (14.8 vs. 9.1, p < 0.0152).
• 1-year survival was 100% for ORN patients versus 28.6% for cancer patients.

Conclusions:

• Significant overlap exists in clinical and radiologic features of ORN and head and neck cancer.
• Standardized Uptake Value maximums (SUVmax) on PET/CT may aid in diagnosis.
• Symptoms appearing within 6 months post-chemoradiotherapy warrant suspicion for malignancy.